| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
N/A |
| Shares
Out: |
61,150,000 |
| Market
Cap: |
6.68(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$113.49 - $145.93 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 845 |
| Guru Rank Value : 2.9 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious diseases with limited or no options. Co.'s primary marketed products are: Xyrem® (sodium oxybate) oral solution, for the treatment of both cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Xywav™ (calcium, magnesium, potassium, and sodium oxybates) oral solution, for the treatment of cataplexy or EDS in narcolepsy patients seven years of age and older; and Sunosi® (solriamfetol), to improve wakefulness in adult patients with EDS associated with narcolepsy or obstructive sleep apnea.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
101,621 |
101,621 |
113,621 |
| Total Buy Value |
$0 |
$9,993,082 |
$9,993,082 |
$11,428,882 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
3 |
| Total Shares Sold |
3,000 |
32,509 |
43,672 |
55,015 |
| Total Sell Value |
$329,790 |
$4,456,744 |
$5,794,346 |
$7,135,003 |
| Total People Sold |
1 |
4 |
5 |
7 |
| Total Sell Transactions |
4 |
14 |
21 |
29 |
| End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hamill Laura |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,807 |
D/D |
(1,805) |
6,933 |
|
- |
|
| Riedel Norbert G |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,806 |
D/D |
(1,805) |
7,024 |
|
- |
|
| Okeefe Kenneth W |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,807 |
D/D |
(1,805) |
28,672 |
|
- |
|
| Mcsharry Heather Ann |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$217,938 |
D/D |
(1,959) |
20,449 |
|
- |
|
| Kennedy Patrick |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$217,940 |
D/D |
(1,959) |
6,702 |
|
- |
|
| Winningham Rick E |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,811 |
D/D |
(1,805) |
14,393 |
|
- |
|
| Smith Mark Douglas |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,807 |
D/D |
(1,805) |
10,837 |
|
- |
|
| Oriordan Anne |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,805 |
D/D |
(1,805) |
16,500 |
|
- |
|
| Cook Jennifer E. |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,805 |
D/D |
(1,805) |
10,837 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2025-08-08 |
4 |
D |
$111.25 |
$200,805 |
D/D |
(1,805) |
26,379 |
|
- |
|
| Hamill Laura |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
8,738 |
|
- |
|
| Riedel Norbert G |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
8,829 |
|
- |
|
| Okeefe Kenneth W |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
30,477 |
|
- |
|
| Mcsharry Heather Ann |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
22,408 |
|
- |
|
| Gala Renee D |
President & CEO |
• – – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,808 |
107,869 |
|
- |
|
| Kennedy Patrick |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
8,661 |
|
- |
|
| Winningham Rick E |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
16,198 |
|
- |
|
| Smith Mark Douglas |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
12,642 |
|
- |
|
| Oriordan Anne |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
18,305 |
|
- |
|
| Cook Jennifer E. |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
12,642 |
|
- |
|
| Mulligan Seamus |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
1,179,613 |
|
- |
|
| Enright Patrick G |
Director |
– • – |
2025-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
28,184 |
|
- |
|
| Pearce Samantha |
EVP, Chief Commercial Officer |
• – – |
2025-08-05 |
4 |
D |
$116.10 |
$66,990 |
D/D |
(577) |
40,815 |
|
- |
|
| Cozadd Bruce C |
Chairman & CEO |
• • – |
2025-08-01 |
4 |
AS |
$113.21 |
$113,210 |
D/D |
(1,000) |
435,973 |
|
- |
|
| Cozadd Bruce C |
Chairman & CEO |
• • – |
2025-07-01 |
4 |
AS |
$105.26 |
$107,630 |
D/D |
(1,000) |
436,973 |
|
- |
|
790 Records found
|
|
Page 1 of 32 |
|
|
0.37 (0.34%) 
